Hillsdale Investment Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History
Bought
Maintained
Sold
Hillsdale Investment Management's KYTH Position: Q4 2015 in Review
Hillsdale Investment Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 500 shares — an estimated $37K sold.
Hillsdale Investment Management first reported a position in KYTH in Q3 2015 and held it in 1 quarter. The position peaked at $37K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.
- Hillsdale Investment Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
- Hillsdale Investment Management sold 500 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $37K.
- Hillsdale Investment Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2015 and held it in 1 quarter.
- Hillsdale Investment Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $37K in Q3 2015.
- 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.
Based on Hillsdale Investment Management's 13F filing for Q4 2015, filed 4 Feb 2016.